Clinical Trial Update: Denosumab for Treating Periprosthetic Osteolysis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating denosumab for periprosthetic osteolysis. The document notes osteolysis as the condition and lists sponsor Olof Skoldenberg wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteolysis
• Periprosthetic Osteolysis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Olof Skoldenberg | Conditions: Osteolysis | Phase 2 | Status: UNKNOWN